Wendy Johnson has over 12 years of experience in clinical laboratories and as a medical laboratory technologist. She has a Bachelor's degree in Biology from the University of North Carolina at Greensboro and a Master's degree in Health Administration from Pfeiffer University. Currently, she works as a Clinical Research Associate coordinating clinical studies for Roche Diagnostics, ensuring studies adhere to regulations and meet objectives. Previously she has worked performing cancer diagnostic testing, newborn genetic screening tests, and specimen processing.
Impact of endometriosis and its staging on assisted reproduction outcome: systematic review and meta-analysis
M.A.P. Barbosa, D. M. Teixeira, P.A.A.S. Navarro, R.A. Ferriani, C. O. Nastri, W. P. Martins
Volume 44, Issue 3, Date: September 2014, Pages 261-278
http://onlinelibrary.wiley.com/doi/10.1002/uog.13366/abstract
Impact of endometriosis and its staging on assisted reproduction outcome: systematic review and meta-analysis
M.A.P. Barbosa, D. M. Teixeira, P.A.A.S. Navarro, R.A. Ferriani, C. O. Nastri, W. P. Martins
Volume 44, Issue 3, Date: September 2014, Pages 261-278
http://onlinelibrary.wiley.com/doi/10.1002/uog.13366/abstract
Introduction to the WCRF International Continuous Update Project
By Dr Rachel Thompson, Head of Research Interpretation/ Head CUP Secretariat
6 December 2014, UICC World Cancer Congress, Melbourne
Webinar Series on Demystifying Phases in Clinical Trials & COVID-19 Updates organized by Institute for Clinical Research (ICR), NIH
Speaker: Dr. Salina Abdul Aziz. MREC Chairperson
More information, please visit: https://clinupcovid.mailerpage.com/resources/p9f2i7-introduction-to-phase-2-3-trial-s
Webinar Series on Demystifying Phases in Clinical Trials & COVID-19 Updates organized by Institute for Clinical Research (ICR), NIH
Speaker: Dr. Alan Fong Yean Yip, Consultant Cardiologist & CRC head of Sarawak General Hospital and Mr. Chew Chun Keat, Technical Head of Centre for Clinical Trial, ICR
More information please visit: https://clinupcovid.mailerpage.com/resources/r0x8r9-webinar-series-on-demystifying-cl
Clinical Research Conduct and Management Certificate Information SessionSarah Benzuly-Nardinelli
Learn to master practical aspects of clinical trial conduct and management, including clinical trial phases and design, planning, implementation, and more. Find out how this program can prepare you for a career in the growing field of clinical research.
Professor Martin Wiseman presentation on The Continuous Update Project: Introduction to the Project at FENS European Nutrition Conference, 20-23 October 2015 Berlin (Germany).
The presentation doc used for the Franklin, MA School Committee meeting on Feb 9, 2021 to provide insights on the proposed pool testing pilot for COVID-19
Biomarker is an objective measure that has been evaluated and confirmed either as an indicator of physiologic health, a pathogenic process or a pharmacologic response to a therapeutic intervention. Biomarkers, whether produces by normal healthy individuals or by individuals affected by specific systemic diseases, are tell tale molecules that could be used to monitor health status, disease onset, treatment response and outcome.The biomarkers can help for the determination of present as well as future disease activity along with diagnosis and previous periodontal diseases.
Introduction to the WCRF International Continuous Update Project
By Dr Rachel Thompson, Head of Research Interpretation/ Head CUP Secretariat
6 December 2014, UICC World Cancer Congress, Melbourne
Webinar Series on Demystifying Phases in Clinical Trials & COVID-19 Updates organized by Institute for Clinical Research (ICR), NIH
Speaker: Dr. Salina Abdul Aziz. MREC Chairperson
More information, please visit: https://clinupcovid.mailerpage.com/resources/p9f2i7-introduction-to-phase-2-3-trial-s
Webinar Series on Demystifying Phases in Clinical Trials & COVID-19 Updates organized by Institute for Clinical Research (ICR), NIH
Speaker: Dr. Alan Fong Yean Yip, Consultant Cardiologist & CRC head of Sarawak General Hospital and Mr. Chew Chun Keat, Technical Head of Centre for Clinical Trial, ICR
More information please visit: https://clinupcovid.mailerpage.com/resources/r0x8r9-webinar-series-on-demystifying-cl
Clinical Research Conduct and Management Certificate Information SessionSarah Benzuly-Nardinelli
Learn to master practical aspects of clinical trial conduct and management, including clinical trial phases and design, planning, implementation, and more. Find out how this program can prepare you for a career in the growing field of clinical research.
Professor Martin Wiseman presentation on The Continuous Update Project: Introduction to the Project at FENS European Nutrition Conference, 20-23 October 2015 Berlin (Germany).
The presentation doc used for the Franklin, MA School Committee meeting on Feb 9, 2021 to provide insights on the proposed pool testing pilot for COVID-19
Biomarker is an objective measure that has been evaluated and confirmed either as an indicator of physiologic health, a pathogenic process or a pharmacologic response to a therapeutic intervention. Biomarkers, whether produces by normal healthy individuals or by individuals affected by specific systemic diseases, are tell tale molecules that could be used to monitor health status, disease onset, treatment response and outcome.The biomarkers can help for the determination of present as well as future disease activity along with diagnosis and previous periodontal diseases.
Traditionally, physicians recruited clinical trial subjects, but pharmaceutical companies have become ever more involved through centralized campaigns. Physicians are vital to a trial and the pharmaceutical effort helps shift some of the recruitment demands away from the site to allow them to focus on the subjects. Thus, it is practical to understand if different recruitment methods could change or skew the study population. This study determines if differences or similarities occurred between subjects recruited by physicians and pharmaceutical companies. It discovered that some of both occurred. The pharmaceutical company efforts helped recruit potential subjects from the general population that were similar to subjects recruited by the physicians, but this particular campaign was limited by language which affected recruitment of Hispanic subjects. The social impact of this study provides insight about pharmaceutical company recruitment. Since the National Library of Medicine has indicated that clinical trials should reflect the broader diseased population, the efforts of the pharmaceutical company can help support the physicians’ efforts by recruiting from the broader population. Together, both efforts can create a global good by allowing the trial to reflect the population of post-approval use. These findings still raise a question about the proper balance between the two recruitment groups so that the intended characteristics of the diseased population are maintained. Because differences between physician and pharmaceutical recruited subjects can exist, the potential of one group to bias the trial results exist. As such, some analysis by recruitment method can help ensure that variations in the study population are minimal without skewing the data to create positive study results.
How evidence affects clinical practice in egyptWafaa Benjamin
Evidence based medicine is the gold standard for clinical care.
It implies the integration of best research evidence with clinical expertise and patient values.
There is still a wide gap between availability of evidence and its incorporation into routine practice in our country.
Barriers to implementation could be personal, social, institutional, financial and legal barriers.
True practice of evidence based care can only occur where evidence based decisions coincide with patients’ beliefs and clinicians’ preferences.
Continuing medical education programs should be set with integrating evidence based medicine teaching and learning within clinical training.
The importance of presence of local national guidelines which need to take into account variation in expertise, resources and patient preferences across our geographical and cultural contexts .
Customisation of a guideline to meet the local needs of a target patient population is critical to successful implementation.
Objective: To evaluate the utility of a targeted lecture in improving FP awareness amongst clinicians.
Design: This is a dual institution, prospective survey-based study assessing if an educational lecture can increase the likelihood of FP consideration, discussion, and referral.
1. Wendy Johnson
Clinical Research Associate
Education
University of North Carolina at Greensboro
Bachelors of Science
Biology
Pfeiffer University
Masters
Health Administration
Summary
• Over 4 years of experience working in a clinical laboratory and over 8 years of experience as a
medical laboratory technologist.
• Clinical Laboratory Areas include:
Oncology
Fluorescence In-Situ Hybridization (FISH) Assay to detect breast cancer
Epidermal Growth Factor Receptor Immuohistochemical (EGFR IHC) Assay to detect colon
cancer and used in clinical trial studies
Nuclear Matrix Protein 22 ELISA Assay to detect bladder cancer
Clinical Chemistry
Isoelectric Focusing (IEF) and High Performance Liquid Chromatography (HPLC) to detect
abnormal hemoglobin disorders
Electrospray Tandem Mass Spectrometry (MS/MS) to identify abnormal disorders of the
metabolism
Molecular Biology
PCR Amplification on high IRT level patients to detect if Cystic Fibrosis mutations were present
2. Professional Experience
DOCS Global
Clinical Research Associate
January 2016-Current
Design, plan, coordinate, and conduct all activities involved in
initiating, monitoring, and completing clinical research studies for in
vitro diagnostics.
Clinical Research Associate
January 2016-Current Agent representing Roche Diagnostics, Clinical Operations
Responsibilities:
• Performing or coordinating aspects of external clinical
studies including site selection, study initiation, site
monitoring, and study close out.
• Maintaining communication with study investigators to
ensure studies are completed in a timely fashion and
ensuring that study objectives are met.
• Interfacing with other Roche staff to support post launch
activities.
• Ensuring that studies adhere to FDA regulations, Good
Clinical Practices, IVD directives, and Roche policies and
procedures.
North Carolina State
Laboratory of Public Health
Medical Laboratory
Technologist
May 2011 to December 2015
Responsible for performing genetic disorder tests (cross-trained) in
all laboratories of Newborn Screening which include:
Hemoglobinopathies, Cystic Fibrosis, and Tandem Mass
Spectrometry.
Responsibilities:
• Interpreted, analyzed, and reported accurate test results of
patients.
• Provided customer service and educational support to
healthcare providers.
• Developed and implemented activities that were indicators
and monitors of accountability in the quality assurance
program (QA program includes test methodologies,
evaluation of patient test results, personnel competence,
communications, quality assurance records review, quality
control, proficiency testing, and complaint investigations).
Johnson_Wendy_15-Jan-2016 Page 2 of 4
3. • Increased quality improvement of receiving patient samples.
LabCorp, Inc.
Oncology Technologist
January 2008 to May 2011
LabCorp, Inc.
Specimen Laboratory
Accessioner
August 2007- December 2007
Performed various prognostic cancer testing such as lung, colon,
bladder, and primarily breast cancer patients.
Responsibilities:
• Evaluated and documented HER-2/neu signal intensity on
slides with an epifluorescence microscope for patient
records. These results helped pathologists determine
quickly if the patient was applicable for the Herceptin (breast
cancer) drug.
• Help initiated and performed clinical trials from global clients
using the Epidermal Growth Factor Receptor (EGFR)
Immunohistochemical (IHC) assay to detect cancer in the
lung and colon tissue.
Received, sorted, and accessioned blood, urine, and saliva
specimens for occupational testing.
Responsibilities:
• Regularly exceeded department sample processing goals by
working overtime as needed to meet deadlines.
• Updated database with patient information to expedite the
process time.
Johnson_Wendy_15-Jan-2016 Page 3 of 4